Our Team
Our team at ABK Biomedical inspires the company mission: research, develop and commercialize breakthrough medical device therapies to improve treatment outcomes and the lives of patients with benign and malignant hypervascular tumors.
ABK Biomedical Leadership Team
ABK Biomedical has assembled expert teams with decades of experience in engineering, material science, oncology, medical science, regulatory, finance, business development, sales, marketing, and clinical study coordination.
The Leadership Team is dedicated to supporting these talented teams that research, develop and manufacture state-of-the-art medical device technologies to treat liver cancer.
Leadership Team
Michael Mangano
> an accomplished global executive leader with over 25 years’ experience in the medical device industry.
Gary Donofrio
> extensive marketing and commercialization experience with over 25 years in the medical device field.
Mike Tyson
> over 35 years’ experience in public accounting and leadership positions.
Aravind Arepally
> Chief Medical Officer and practicing Interventional Radiologist with extensive industry and academic experience.
David Dobrowski
> an accomplished Life Sciences Executive and Enterprise Leader with over 25 years of pharmaceutical and medical device development experience.
Mark Gregoire
> an accomplished professional mechanical engineer with extensive experience in the nuclear medical products sector.
Anthony Headley
> an accomplished medical device executive with 25 years experience leading and building engineering, manufacturing, and R&D organizations.
Board of Directors
Aaron Berez
> investor, advisor, and director focused on capital-efficient medical device development.
Michael Mangano
> an accomplished global executive leader with over 25 years’ experience in the medical device industry.
Ketan Patel
> Partner with F-Prime Capital and has worked in the healthcare sector as an investor, consultant, and physician.
Carissa Bellardine Black
> Director of Venture Capital, Medtronic
James Eadie
> executive and military veteran with an extensive background in the healthcare industry.
James McLaren
> executive with an extensive background in corporate finance and the healthcare industry.
Clinical Advisory Board
Andrew Kennedy
> Physician in Chief, Radiation Oncology, Sarah Cannon Research Institute, Nashville, TN.
Cheenu Kappadath
>Associate Professor, Division of Diagnostic Imaging, MD Anderson Cancer Center, Houston, TX
Robert Lewandowski
> Professor of Radiology, Medicine, and Surgery, Northwestern University, Chicago, Il
David Liu
> Clinical Professor, University of British Columbia, BC
Armeen Mahvash
> Professor, Department of Interventional Radiology, Division of Diagnostic Imaging, MD Anderson, Houston, TX
Charles Nutting
> Founder, Endovascular Consultants of Colorado, Lone Tree, CO
The ABK Biomedical Team
We are dedicated to encouraging a stimulating work environment offering an opportunity to significantly expand experience and skills by researching, developing, and commercializing cutting-edge medical device technologies with a mandate to effectively treat cancer.
ABK Biomedical is an equal opportunity employer offering competitive compensation packages.
ABK's Business Partners
ABK Biomedical is proud to partner with cutting-edge organizations and individuals with exceptional skills, scientific expertise, and the highest business ethics.
Research Partners
Development Partners
Corporate Offices
Halifax Office (Main Office)
155 Chain Lake Drive
Unit 32
Halifax, NS B3S 1B3
Canada
T. 902.442.4009
Orange County Office
555 Corporate Drive
Suite 105
Ladera Ranch, CA, 92694
USA
ABK Biomedical Inc. provides and continues to provide accurate information on its website. However, ABK Biomedical Inc. assumes no responsibility for the accuracy and/or completeness, express or implied, as to the information contained or omitted and/or the products described. Furthermore, ABK Biomedical Inc. may change the products mentioned, and their stage in development, at any time without notice. ABK Biomedical Inc. is a clinical-stage company engaged in the research and development of new medical devices. Eye90 microspheres® is considered an investigational product and is NOT FDA-approved for use.
Copyright 2022 - All International Rights Reserved